Strategic Partners A/S
Research Strategic Partners A/S (1TB0) on Bullrun: market cap EUR 4.94M, P/E 22.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1TB0
- ExchangeF
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 4.94M
- P/E22.2
- Financial periodFY2025
- RevenueDKK 309.00K
- Net income-DKK 859.00K
- Free cash flow-DKK 2.14M
- Gross margin11.0%
Valuation Snapshot
latest market cap is EUR 4.94M; P/E is 22.2.
Peer valuation comparison
Latest P/E is 22.17x versus a Healthcare sector median of 24.46x (9.4% below).
Latest P/E is 22.17x versus a Denmark median of 19.06x (16.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | DKK 309.00K | -DKK 859.00K | -DKK 2.14M | 11.0% | -49 | DKK 394.00K | n/a | DKK 18.39M |
| FY2024 | DKK 0 | -DKK 298.00K | -DKK 3.36M | n/a | -8 | DKK 3.89M | n/a | DKK 19.25M |
| FY2023 | DKK 0 | -DKK 26.05M | -DKK 20.02M | n/a | -738 | DKK 11.27M | n/a | DKK 14.24M |
| FY2022 | DKK 0 | DKK 26.07M | -DKK 117.95M | n/a | 0.74 | DKK 42.46M | DKK 0 | DKK 78.21M |
| FY2021 | DKK 0 | -DKK 626.54M | -DKK 603.57M | n/a | -17940 | DKK 102.26M | DKK 39.97M | DKK 9.34M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 4.94M | 22.2 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Strategic Partners A/S
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Strategic Partners A/S's market cap?
Strategic Partners A/S's market capitalization is EUR 4.94M.
What is Strategic Partners A/S's P/E ratio?
Strategic Partners A/S's price-to-earnings (P/E) ratio is 22.2.
What does Strategic Partners A/S do?
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.